[Occlusion therapy in chronic recurrent parotitis? A report of clinical experiences with the use of a fibrin glue-gentamycin mixture].
Treatment of chronic recurrent parotitis was attempted in 12 patients by occlusion of Stensen's duct with a mixture of fibrin glue and gentamycin. This therapy failed to induce long-term improvement. It is recommended to undertake surgical intervention as soon as possible in all cases of progressive chronic recurrent parotitis.
Laskawi
R
R
Klinik für Hals-Nasen-Ohrenheilkunde der Universität Göttingen.
Shröder
J
J
Brauneis
J
J
D007611:Aprotinin / Q000008:administration & dosage*; D002908:Chronic Disease; D004338:Drug Combinations / Q000008:administration & dosage; D005176:Factor XIII / Q000008:administration & dosage*; D015718:Fibrin Tissue Adhesive; D005340:Fibrinogen / Q000008:administration & dosage*; D005500:Follow-Up Studies; D005839:Gentamicins / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D008768:Methylmethacrylates / Q000008:administration & dosage*; D010306:Parotid Gland / Q000187:drug effects*; D010309:Parotitis / Q000628:therapy*; D012008:Recurrence; D013917:Thrombin / Q000008:administration & dosage*
D004338:Drug Combinations; D015718:Fibrin Tissue Adhesive; D005839:Gentamicins; D008768:Methylmethacrylates; C030159:gentamicin-polymethylmethacrylate bead; D005340:Fibrinogen; D005176:Factor XIII; D007611:Aprotinin; D013917:Thrombin
Okklusionstherapie bei chronisch rezidivierender Parotitis? Ein klinischer Erfahrungsbericht über die Anwendung eines Fibrinkleber-Gentamycin-Gemisches.